Inactive Instrument

ICON plc Share Price Nasdaq

Equities

US45103T1079

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets
- ^USD	-

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Press releases ICON plc

ICON plc : ICON and DIA to Deliver Webinar on Clinical Outcome Assessments	03/09/13	PU
ICON plc : ICON Launches New Monitoring Service to Improve Quality and Reduce Costs	21/08/13	PU
ICON plc : ICON Signs Collaboration Agreement with the Taiwan National Centre of Excellence for Clinical Trials and Research	07/08/13	PU
ICON plc : ICON Reports second quarter 2013 Revenue of $334 million, up 21% year on year, non-GAAP EPS of 43c and raises FY 2013 Guidance.	25/07/13	PU
ICON plc : ICON shareholders vote in favour of all resolutions at its Annual General Meeting	23/07/13	PU

More press releases

News in other languages on ICON plc

Icon : annonce l'achèvement d'un "fractionnement d'actions"

14/08/08

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+43.36%	54.63B
IQVIA HOLDINGS INC.	-5.31%	39.92B
ICON PUBLIC LIMITED COMPANY	+14.75%	26.86B
CELLTRION, INC.	-12.56%	26.22B
ALNYLAM PHARMACEUTICALS, INC.	-22.45%	18.78B
UNITED THERAPEUTICS CORPORATION	+25.12%	12.21B
BIO-TECHNE CORPORATION	+0.04%	12.16B
MEDPACE HOLDINGS, INC.	+26.04%	11.94B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-11.83%	10.74B

Other Biotechnology & Medical Research

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW